Pfizer
PFE
PFE
2,894 hedge funds and large institutions have $109B invested in Pfizer in 2024 Q3 according to their latest regulatory filings, with 189 funds opening new positions, 1,238 increasing their positions, 1,192 reducing their positions, and 125 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% more capital invested
Capital invested by funds: $105B → $109B (+$3.79B)
0.36% more ownership
Funds ownership: 65.94% → 66.3% (+0.36%)
38% less call options, than puts
Call options by funds: $2.51B | Put options by funds: $4.05B
Holders
2,894
Holding in Top 10
40
Calls
$2.51B
Puts
$4.05B
Top Buyers
| 1 | +$421M | |
| 2 | +$372M | |
| 3 | +$343M | |
| 4 |
BlackRock
New York
|
+$336M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$284M |
Top Sellers
| 1 | -$997M | |
| 2 | -$357M | |
| 3 | -$263M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$261M |
| 5 |
DCP
D1 Capital Partners
New York
|
-$213M |